Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
6,887,242
-
Total 13F shares
-
1,618,851
-
Share change
-
-198,357
-
Total reported value
-
$2,387,744
-
Price per share
-
$1.48
-
Number of holders
-
23
-
Value change
-
-$296,033
-
Number of buys
-
6
-
Number of sells
-
8
Institutional Holders of Aprea Therapeutics, Inc. - Common Stock (APRE) as of Q3 2025
As of 30 Sep 2025,
Aprea Therapeutics, Inc. - Common Stock (APRE) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,618,851 shares.
The largest 10 holders included
AIGH Capital Management LLC, SPHERA FUNDS MANAGEMENT LTD., Nantahala Capital Management, LLC, VANGUARD GROUP INC, DAFNA Capital Management LLC, Sio Capital Management, LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, BNP PARIBAS FINANCIAL MARKETS, and LPL Financial LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.